EUVIMEDEUVIMED entdecken
Crossref

Patch Testing to Chlorhexidine Digluconate, 1% Aqueous: North American Contact Dermatitis Group Experience, 2015–2020

Erin M Warshaw iD, Joohee Han, Sara A Kullberg, Joel G DeKoven, Brandon L Adler iD, Jonathan I Silverberg iD, Marie-Claude Houle, Melanie D Pratt, Donald V Belsito iD, Jiade Yu, Nina C Botto, Margo J Reeder und 5 weitere

Dermatitis® · 2023

DOI: 10.1089/derm.2023.0077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatitis®, 2023. Verfasst von Erin M Warshaw und 16 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Dermatology, Park Nicollet Health Services, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Dermatitis, Occupational, Dermatitis, Allergic Contact. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chlorhexidine is an antiseptic that may cause allergic contact dermatitis.

Objectives

To describe the epidemiology of chlorhexidine allergy and characterize positive patch test reactions.

Methods

This retrospective study analyzed patients patch tested to chlorhexidine digluconate 1% aqueous by the North American Contact Dermatitis Group, 2015–2020.

Results

Of 14,731 patients tested to chlorhexidine digluconate, 107 (0.7%) had an allergic reaction; of these, 56 (52.3%) reactions were currently clinically relevant. Most (59%) reactions were mild (+), followed by strong (++, 18.7%) and very strong (+++, 6.5%). Common primary dermatitis anatomic sites in chlorhexidine-positive patients were hands (26.4%), face (24.5%), and scattered/generalized distribution (17.9%). Compared with negative patients, chlorhexidine-positive patients were significantly more likely to have dermatitis involving the trunk (11.3% vs 5.1%; P = 0.0036). The most commonly identified source category was skin/health care products (n = 41, 38.3%). Only 11 (10.3%) chlorhexidine reactions were occupationally related; of these, 81.8% were in health care workers.

Conclusions

Chlorhexidine digluconate allergy is uncommon, but often clinically relevant. Involvement of the hands, face, and scattered generalized patterns was frequent. Occupationally related reactions were found predominantly in health care workers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, OccupationalDermatitis, Allergic ContactHumansChlorhexidinePatch TestsRetrospective StudiesNorth AmericaAllergens

Substanzen

chlorhexidine gluconateChlorhexidineAllergens

Autor:innen und Institutionen

  • From the Department of Dermatology, Park Nicollet Health Services, Minneapolis, Minnesota, USA.
  • Department of Dermatology, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota, USA.
  • Department of Dermatology, University of Minnesota, Minneapolis, Minnesota, USA.
  • University of Minnesota Medical School, Minneapolis, Minnesota, USA.
  • Division of Dermatology, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada.
  • Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

ORCID-Profile: Erin M Warshaw, Brandon L Adler, Jonathan I Silverberg, Donald V Belsito, Amber R Atwater

Zitieren

APA

Warshaw, E. M., Han, J., Kullberg, S. A., DeKoven, J. G., Adler, B. L., Silverberg, J. I., Houle, M. C., Pratt, M. D., Belsito, D. V., Yu, J., Botto, N. C., Reeder, M. J., Taylor, J. S., Atwater, A. R., Dunnick, C. A., DeLeo, V. A., & Mowad, C. M. (2023). Patch Testing to Chlorhexidine Digluconate, 1% Aqueous: North American Contact Dermatitis Group Experience, 2015–2020. Dermatitis®. https://doi.org/10.1089/derm.2023.0077

Vancouver

Warshaw EM, Han J, Kullberg SA, DeKoven JG, Adler BL, Silverberg JI, et al. Patch Testing to Chlorhexidine Digluconate, 1% Aqueous: North American Contact Dermatitis Group Experience, 2015–2020. Dermatitis®. 2023. doi:10.1089/derm.2023.0077

BibTeX
@article{Warshaw2023,
  author = {Warshaw, Erin M and Han, Joohee and Kullberg, Sara A and DeKoven, Joel G and Adler, Brandon L and Silverberg, Jonathan I and Houle, Marie-Claude and Pratt, Melanie D and Belsito, Donald V and Yu, Jiade and Botto, Nina C and Reeder, Margo J and Taylor, James S and Atwater, Amber R and Dunnick, Cory A and DeLeo, Vincent A and Mowad, Chris M},
  title = {Patch Testing to Chlorhexidine Digluconate, 1% Aqueous: North American Contact Dermatitis Group Experience, 2015–2020},
  journal = {Dermatitis®},
  year = {2023},
  doi = {10.1089/derm.2023.0077}
}
Kostenlos starten →